| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1989PNAS...86.6753G |
| P356 | DOI | 10.1073/PNAS.86.17.6753 |
| P932 | PMC publication ID | 297924 |
| P698 | PubMed publication ID | 2549546 |
| P5875 | ResearchGate publication ID | 20605699 |
| P2093 | author name string | Lange LG | |
| Schreiner GF | |||
| Gulick T | |||
| Chung MK | |||
| Pieper SJ | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Interleukin 1 inhibits contraction of vascular smooth muscle | Q34565083 | ||
| Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells | Q36348048 | ||
| Leukocytic infiltrates in idiopathic dilated cardiomyopathy. A source of confusion with active myocarditis | Q39735413 | ||
| Cardiac transplantation: immune mechanisms and alloantigens involved in graft rejection | Q39758004 | ||
| Rejection of the transplanted heart | Q39764841 | ||
| Myocarditis and dilated cardiomyopathy | Q39767216 | ||
| Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes | Q41916354 | ||
| Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. | Q53541288 | ||
| 3HCGP-12177, A β-Adrenergic Ligand Suitable for Measuring Cell Surface Receptors | Q55489616 | ||
| Human cardiac transplantation--evaluation of morphological changes in serial endomyocardial biopsies | Q69887339 | ||
| Left ventricular contractility and contractile reserve in humans after cardiac transplantation | Q69888768 | ||
| New method for preparing large surfaces of intact human basement membrane for tumor invasion studies | Q71470206 | ||
| Exercise response of the denervated heart in long-term cardiac transplant recipients | Q71514162 | ||
| Diagnosis and classification of myocarditis by endomyocardial biopsy | Q71759284 | ||
| Desensitization to parathyroid hormone in the isolated perfused canine kidney: reversal of altered receptor-adenylate cyclase system by guanosine triphosphate in vitro | Q72950199 | ||
| In vitro studies on single beating rat heart cells. I. Growth and organization | Q79514563 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 6753-6757 | |
| P577 | publication date | 1989-09-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness | |
| P478 | volume | 86 |
| Q42150024 | A comparison of etanercept vs. infliximab for the treatment of post-arrest myocardial dysfunction in a swine model of ventricular fibrillation |
| Q28180984 | ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytes |
| Q36072891 | Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6. |
| Q71918858 | Alterations in inotropy, nitric oxide and cyclic GMP synthesis, protein phosphorylation and ADP-ribosylation in the endotoxin-treated rat myocardium and cardiomyocytes |
| Q35536642 | Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study |
| Q28582056 | CXCR4 modulates contractility in adult cardiac myocytes |
| Q31159585 | Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions |
| Q74571400 | Can molecular techniques be applied to improve the endomyocardial biopsy diagnosis of acute rejection? |
| Q35250425 | Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation |
| Q38046798 | Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? |
| Q31058267 | Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic heart failure |
| Q35807000 | Case report: severe reversible cardiomyopathy associated with systemic inflammatory response syndrome in the setting of diabetic hyperosmolar hyperglycemic non-ketotic syndrome. |
| Q43640228 | Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts |
| Q33907789 | Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart |
| Q48909371 | Changes in noradrenergic sensitivity to tumor necrosis factor-alpha in brains of rats administered clonidine |
| Q28211327 | Chronic heart failure and the immune system |
| Q34774421 | Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia |
| Q24807147 | Clinical review: Myocardial depression in sepsis and septic shock |
| Q38112347 | Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development |
| Q37845437 | Current issues in clinical and experimental cardiac transplantation |
| Q71790523 | Cytokine Induction During Cardiac Surgery: Analysis of TNF-? Expression Pre-and Postcardiopulmonary Bypass |
| Q35796148 | Cytokine mRNA expression in postischemic/reperfused myocardium. |
| Q41605525 | Cytokine regulation of adenylate cyclase activity in LLC-PK1 cells |
| Q36188431 | Cytokines and cardiovascular disease |
| Q24799394 | Cytokines as new treatment targets in chronic heart failure |
| Q43601748 | Cytokines induce stress protein formation in cultured cardiac myocytes |
| Q34774468 | Cytokines, apoptosis and cachexia: the potential for TNF antagonism |
| Q53990493 | DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure. |
| Q46430408 | Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice |
| Q55363616 | Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure. |
| Q42057890 | Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin |
| Q55067951 | Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart. |
| Q54570871 | Depression of the inotropic action of isoprenaline by nitric oxide synthase induction in rat isolated hearts. |
| Q34574280 | Diagnosis and management of pediatric myocarditis |
| Q34916463 | Do cardiomyocytes mount an immune response to Group A Streptococcus? |
| Q43106078 | Downregulation of oxytocin receptors in right ventricle of rats with monocrotaline-induced pulmonary hypertension |
| Q24673703 | Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat |
| Q35872942 | Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells |
| Q28575642 | Effects of burn injury on myocardial signaling and cytokine secretion: Possible role of PKC |
| Q43905542 | Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice |
| Q51033989 | Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. |
| Q40743489 | Effects of human recombinant interleukin-1β on protein synthesis in rat tissues compared with a classical acute-phase reaction induced by turpentine. Rapid response of muscle to interleukin-1β |
| Q73270250 | Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect |
| Q41281016 | Elucidating molecular mechanisms of septic cardiomyopathy--the cardiomyocyte model |
| Q28731260 | Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure |
| Q54545982 | Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. |
| Q77802837 | Evidence of phenotypic alteration as a cause of systolic dysfunction in the failing heart |
| Q56027585 | Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: Role of β-catenin transduction and cell dose |
| Q70930170 | Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis |
| Q72034108 | Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium |
| Q77398515 | Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart |
| Q40131494 | Gas gangrene |
| Q36698712 | Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy |
| Q34175968 | Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation |
| Q44558881 | Growth hormone induces myocardial expression of creatine transporter and decreases plasma levels of IL-1beta in rats during early postinfarct cardiac remodeling |
| Q42772150 | Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction |
| Q43640242 | Hemorrhage-induced alpha-adrenergic signaling results in myocardial TNF-alpha expression and contractile dysfunction |
| Q37158219 | Hypertension in rheumatoid arthritis. |
| Q42317785 | IP3R and RyR calcium channels are involved in neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α. |
| Q89964322 | Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome |
| Q34513186 | Immune and neurohormonal pathways in chronic heart failure |
| Q42077100 | Immune modulation of cardiac cell function |
| Q47756011 | Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets |
| Q73226918 | Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change |
| Q74709482 | Impact of an exercise-induced increase in cardiac troponin I in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy |
| Q36833376 | Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease |
| Q47702997 | Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d |
| Q42712096 | Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium |
| Q58735426 | Inflammation in Right Ventricular Failure: Does It Matter? |
| Q45165309 | Inflammation in chronic heart failure |
| Q26849245 | Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery |
| Q36204135 | Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis |
| Q33753939 | Infliximab attenuates early myocardial dysfunction after resuscitation in a swine cardiac arrest model |
| Q36214658 | Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease |
| Q41881758 | Inotropic response to endothelin-1, isoprenaline and calcium in cardiomyocytes isolated from endotoxin treated rats: effects of ethyl-isothiourea and dexamethasone |
| Q34222993 | Interactions between cytokines and neurohormonal systems in the failing heart |
| Q51015874 | Interleukin-1β induces a reversible cardiomyopathy in the mouse. |
| Q34070335 | Interleukin-1β reduces L-type Ca2+ current through protein kinase Cϵ activation in mouse heart |
| Q41468713 | Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction |
| Q78408670 | Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis |
| Q35604862 | Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs |
| Q34718320 | Lipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitro |
| Q40913112 | Local contractile and growth modulators in the myocardium |
| Q68270121 | Mechanisms in acute septic cardiomyopathy: evidence from isolated myocytes |
| Q37360743 | Mechanisms of impaired beta-adrenoceptor-induced airway relaxation by interleukin-1beta in vivo in the rat. |
| Q37078877 | Molecular events in the cardiomyopathy of sepsis |
| Q61850267 | Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy |
| Q26784080 | Myocardial Dysfunction and Shock after Cardiac Arrest |
| Q37300178 | Myocardial cytokine IL-8 and nitric oxide synthase activity during and after resuscitation: preliminary observations in regards to post-resuscitation myocardial dysfunction |
| Q33893312 | Myocardial dysfunction in septic shock |
| Q40399475 | Nitric oxide and the pathogenesis of heart muscle disease |
| Q41101397 | Nitric oxide in sepsis |
| Q42507063 | Nitric oxide-dependent and -independent mechanisms are involved in TNF-alpha -induced depression of cardiac myocyte contractility |
| Q44412405 | Norepinephrine-induced expression of cytokines in isolated biventricular working rat hearts |
| Q46869113 | Organ culture with proinflammatory cytokines reproduces impairment of the beta-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model |
| Q35761448 | Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both? |
| Q37990356 | Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
| Q39070066 | Pro-inflammatory cytokines mediate GPCR dysfunction |
| Q47126052 | Proinflammatory Cytokines Are Soluble Mediators Linked with Ventricular Arrhythmias and Contractile Dysfunction in a Rat Model of Metabolic Syndrome |
| Q71952429 | Prostacyclin counteracts the increase in capillary permeability induced by tumour necrosis factor-alpha |
| Q63488655 | Quantification of proinflammatory cytokines in the urine of congestive heart failure patients. Its relationship with plasma levels |
| Q58135634 | Reaction of Human Endothelial Cells to Bovine Hemoglobin Solutions and Tumor Necrosis Factor |
| Q92860844 | Reappraising the role of inflammation in heart failure |
| Q36810269 | Recent advances of TNF-alpha antagonists in rheumatoid arthritis and chronic heart failure |
| Q34222962 | Recent insights into the role of tumor necrosis factor in the failing heart. |
| Q37951309 | Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization |
| Q44160585 | Relation of tissue Doppler-derived myocardial velocities to serum levels and myocardial gene expression of tumor necrosis factor-alpha and inducible nitric oxide synthase in patients with ischemic cardiomyopathy having coronary artery bypass graftin |
| Q80814292 | Role of PKCs and NF-kappaB activation in myocardial inflammation: enemy or ally? |
| Q35609202 | Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1 |
| Q55318421 | Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction. |
| Q50866420 | Sepsis is associated with an upregulation of functional beta3 adrenoceptors in the myocardium. |
| Q39167276 | Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis. |
| Q35687065 | Sepsis-induced cardiomyopathy |
| Q40528418 | Signaling pathways for cardiac growth and hypertrophy. Recent advances and prospects for growth factor therapy. |
| Q37708944 | Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study |
| Q59192165 | Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte |
| Q73206649 | Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor alpha attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations |
| Q35782883 | TNF and congestive heart failure: therapeutic possibilities |
| Q37767172 | TNFα in myocardial ischemia/reperfusion, remodeling and heart failure |
| Q90652581 | The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure |
| Q52642556 | The Trend of β3-Adrenergic Receptor in the Development of Septic Myocardial Depression: A Lipopolysaccharide-Induced Rat Septic Shock Model. |
| Q34167756 | The cytokine response to physical activity and training |
| Q38375149 | The duality of chemokines in heart failure |
| Q41844798 | The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats |
| Q34201359 | The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta |
| Q36192931 | The neurohormonal axis and biochemical markers of heart failure |
| Q37460270 | The role of IL-1 in the pathogenesis of heart disease. |
| Q35106477 | The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials? |
| Q33824143 | The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. |
| Q34027484 | The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure |
| Q33862430 | The role of tumor necrosis factor in the pathophysiology of heart failure |
| Q33334925 | The systemic inflammatory response in heart failure |
| Q40361542 | The tumor necrosis factor superfamily in heart failure |
| Q35026157 | Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart. |
| Q82971464 | Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide |
| Q21296645 | Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases |
| Q70587091 | Transient left ventricular aneurysm in a patient with hypertrophic cardiomyopathy and myocarditis |
| Q34185457 | Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production |
| Q43676699 | Trypanosoma cruzi infection induces up-regulation of cardiac muscarinic acetylcholine receptors in vivo and in vitro |
| Q91794636 | Tumor Necrosis Factor-α in Heart Failure: an Updated Review |
| Q41903981 | Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum |
| Q42500393 | Tumor necrosis factor alpha decreases inositol phosphate formation and phosphatidylinositol-bisphosphate (PIP2) synthesis in rat cardiomyocytes |
| Q40376550 | Tumor necrosis factor-alpha and the failing human heart |
| Q33826955 | Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration |
| Q54953158 | Tumor necrosis factor-α and its role as a mediator in myocardial infarction: A brief review. |
| Q38663003 | Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases. |
| Q30319434 | Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms |
Search more.